PacBio Files Q1 2024 10-Q
Ticker: PACB · Form: 10-Q · Filed: 2024-05-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
PacBio's Q1 2024 10-Q is in: check financials for product & service revenue.
AI Summary
Pacific Biosciences of California, Inc. filed its 10-Q for the period ending March 31, 2024. The company reported revenue from product sales and services. Key financial figures and operational details for the first quarter of 2024 are presented in this filing.
Why It Matters
This filing provides investors with an update on Pacific Biosciences' financial performance and operational status for the first quarter of 2024, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the specific financial performance and market conditions detailed within can present varying levels of risk.
Key Numbers
- 2024-03-31 — Report End Date (Quarterly reporting period)
- 2024-01-01 — Report Start Date (Quarterly reporting period)
- 2023-12-31 — Previous Year End Date (Reference for comparative periods)
- 2023-03-31 — Prior Year Quarter End Date (Comparative period for Q1 2024)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer
- 20240331 (date) — Period of Report
- 20240509 (date) — Filing Date
- 1305 O'BRIEN DRIVE (address) — Business Address
- MENLO PARK (location) — City
- CA (location) — State
- 94025 (zip_code) — ZIP Code
- 650-521-8000 (phone_number) — Business Phone
FAQ
What was Pacific Biosciences' revenue from product sales for the quarter ended March 31, 2024?
The filing indicates revenue from product sales for the period January 1, 2024 to March 31, 2024, but the specific dollar amount is not provided in this header information.
What was the revenue from services and other for the quarter ended March 31, 2024?
The filing references revenue from 'ServiceAndOtherMember' for the period January 1, 2024 to March 31, 2024, but the specific dollar amount is not detailed in this header.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
When was the company formerly known as Nanofluidics Inc.?
The company was formerly known as Nanofluidics Inc. with a date of name change on 20040729.
What is the SEC file number for Pacific Biosciences of California, Inc.?
The SEC file number is 001-34899.
From the Filing
0001299130-24-000111.txt : 20240509 0001299130-24-000111.hdr.sgml : 20240509 20240509162146 ACCESSION NUMBER: 0001299130-24-000111 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 24931062 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 10-Q 1 pacb-20240331.htm 10-Q pacb-20240331 0001299130 12-31 2024 Q1 false P20D one-year 0.0229885 0.046512 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001299130 2024-01-01 2024-03-31 0001299130 2024-04-30 0001299130 2024-03-31 0001299130 2023-12-31 0001299130 us-gaap:ProductMember 2024-01-01 2024-03-31 0001299130 us-gaap:ProductMember 2023-01-01 2023-03-31 0001299130 pacb:ServiceAndOtherMember 2024-01-01 2024-03-31 0001299130 pacb:ServiceAndOtherMember 2023-01-01 2023-03-31 0001299130 2023-01-01 2023-03-31 0001299130 us-gaap:CommonStockMember 2023-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001299130 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001299130 us-gaap:CommonStockMember 2024-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001299130 us-gaap:RetainedEarningsMember 2024-03-31 0001299130 us-gaap:CommonStockMember 2022-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001299130 us-gaap:RetainedEarningsMember 2022-12-31 0001299130 2022-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001299130 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001299130 us-gaap:CommonStockMember 2023-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001299130 us-gaap:RetainedEarningsMember 2023-03-31 0001299130 2023-03-31 0001299130 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember pacb:DomesticCustomersMember 2024-01-01 2024-03-31 0001299130 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember pacb:DomesticCustomersMember 2023-01-01 2023-12-31 0001299130 pacb:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001299130 pacb:AptonMember 2023-08-02 2023-08-02 0001299130 pacb:AptonMember 2023-08-02 0001299130 pacb:AptonMember pacb:AchievementOfMilestoneMember 2023-08-02 0001299130 pacb:AptonMember srt:MaximumMember 2023-08-02 2023-08-02 0001299130 pacb:AptonMember 2023-12-31 0001299130 pacb:AptonMember 2023-01-01 2023-12-31 0001299130 us-gaap:CommonStockMember pacb:AptonMember 2023-01-01 2023-12-31 0001299130 us-gaap:FairValueInputsLevel1Member 2024-03-3